Northern Trust
MIST icon

Northern Trust’s Milestone Pharmaceuticals MIST Stock Holding History

Northern Trust’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,779
Closed -$46.1K – 4521
2026
Q1 		$46.1K Sell
38,779
-479
-1% -$839 ﹤0.01% 4256
2025
Q4 		$79.3K Hold
39,258
– – ﹤0.01% 4181
2025
Q3 		$78.5K Sell
39,258
-13,743
-26% -$24.2K ﹤0.01% 4189
2025
Q2 		$103K Hold
53,001
– – ﹤0.01% 4105
2025
Q1 		$42.4K Sell
53,001
-5,107
-9% -$10.2K ﹤0.01% 4248
2024
Q4 		$137K Buy
58,108
+30,772
+113% +$52.8K ﹤0.01% 4094
2024
Q3 		$41.5K Sell
27,336
-448
-2% -$652 ﹤0.01% 4242
2024
Q2 		$36.7K Sell
27,784
-532
-2% -$855 ﹤0.01% 4257
2024
Q1 		$50.7K Sell
28,316
-3,654
-11% -$5.93K ﹤0.01% 4225
2023
Q4 		$53.4K Buy
+31,970
New +$86.8K ﹤0.01% 4229

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Northern Trust's MIST Position: Q2 2026 in Review

Northern Trust sold out of Milestone Pharmaceuticals (MIST) in Q2 2026, closing a stake of 38,779 shares — an estimated $46.1K sold.

Northern Trust first reported a position in MIST in Q4 2023 and held it in 10 quarters. The position peaked at $137K in Q4 2024. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Northern Trust reported no remaining Milestone Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Northern Trust sold 38,779 Milestone Pharmaceuticals shares in Q2 2026, an estimated $46.1K.
  • Northern Trust first reported a position in Milestone Pharmaceuticals in Q4 2023 and held it in 10 quarters.
  • Northern Trust's Milestone Pharmaceuticals position peaked at $137K in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.